敵のシステムです.

J E Mack¹

¹Center for Psychological Studies in the Nuclear Age, Harvard Medical School, Cambridge, Massachusetts 02139.

Lancet (London, England)

|August 13, 1988

まとめ

No abstract available in PubMed .

関連する概念動画

こちらも読む

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Channel electron multiplier: its quantum efficiency at soft x-ray and vacuum ultraviolet wavelengths.

Applied optics·2010

Same author

Neuroleptic malignant syndrome during a change from haloperidol to risperidone.

The Annals of pharmacotherapy·2001

Same author

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1999

Same author

Power, powerlessness, and empowerment in psychotherapy.

Psychiatry·1994

Same author

How AA works and why it's important for clinicians to understand.

Journal of substance abuse treatment·1994

Same author

Comparison of cold and warm ischemic injury in hepatocytes from the rat liver.

Transplantation proceedings·1993

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

敵のシステムです.

関連する概念動画

Channel electron multiplier: its quantum efficiency at soft x-ray and vacuum ultraviolet wavelengths.

Neuroleptic malignant syndrome during a change from haloperidol to risperidone.

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Power, powerlessness, and empowerment in psychotherapy.

How AA works and why it's important for clinicians to understand.

Comparison of cold and warm ischemic injury in hepatocytes from the rat liver.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

敵のシステムです.

関連する概念動画

Channel electron multiplier: its quantum efficiency at soft x-ray and vacuum ultraviolet wavelengths.

Neuroleptic malignant syndrome during a change from haloperidol to risperidone.

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Power, powerlessness, and empowerment in psychotherapy.

How AA works and why it's important for clinicians to understand.

Comparison of cold and warm ischemic injury in hepatocytes from the rat liver.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

敵のシステムです.

関連する概念動画

関連記事

Channel electron multiplier: its quantum efficiency at soft x-ray and vacuum ultraviolet wavelengths.

Neuroleptic malignant syndrome during a change from haloperidol to risperidone.

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Power, powerlessness, and empowerment in psychotherapy.

How AA works and why it's important for clinicians to understand.

Comparison of cold and warm ischemic injury in hepatocytes from the rat liver.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

敵のシステムです.

関連する概念動画

関連記事

Channel electron multiplier: its quantum efficiency at soft x-ray and vacuum ultraviolet wavelengths.

Neuroleptic malignant syndrome during a change from haloperidol to risperidone.

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Power, powerlessness, and empowerment in psychotherapy.

How AA works and why it's important for clinicians to understand.

Comparison of cold and warm ischemic injury in hepatocytes from the rat liver.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.